Background: The randomized EAST-AFNET4 (Early Treatment of Atrial Fibrillation for Stroke
Prevention Trial–Atrial Fibrillation Network) demonstrated that early rhythm control (ERC) …

Beta thalassemia is an inherited disorder resulting in abnormal or decreased production of
hemoglobin, leading to hemolysis and chronic anemia. The long-term complications can …

Cardioembolic stroke from atrial fibrillation causes substantial death and disability in the
United States. Treatment with oral anticoagulants provides safe and effective stroke …

Aims To evaluate outcomes of percutaneous left atrial appendage closure (LAAC) in
patients with congestive heart failure (CHF) and non‐valvular atrial fibrillation (AF) in a …

Background Integrating patient-specific cardiac implantable electronic device (CIED)-
detected atrial fibrillation (AF) burden with measures of health care cost and utilization …

The left atrial appendage (LAA) is a complex structure with unknown physiologic function
protruding from the main body of the left atrium. In patients with atrial fibrillation, the left …

Background Examining characteristics of patients with atrial fibrillation (AF) has the potential
to help in identifying groups of patients who might benefit from different management …

Atrial fibrillation (AF) prevalence increases in older patients which also show a high
thromboembolic risk. Oral anticoagulants (OACs) are recommended to prevent …

Nonvalvular atrial fibrillation (NVAF) and carotid stenosis are important risk factors for stroke.
Carotid angioplasty and stent placement (CAS) is recommended for patients with …

Introduction Limited data on atrial fibrillation (AF) are available from the Middle East and
North Africa region (MENA). The aim of the FLOW-AF registry was to evaluate the …